Concord Medical Co., Ltd. (TPEX:6518)
27.30
-0.05 (-0.18%)
At close: Mar 27, 2026
Concord Medical Market Cap
Concord Medical has a market cap or net worth of 910 million as of March 27, 2026. Its market cap has increased by 4.60% in one year.
Market Cap
910.00M
Enterprise Value
989.42M
Revenue
964.35M
Ranking
n/a
PE Ratio
13.58
Stock Price
27.30
Market Cap Chart
Since May 13, 2015, Concord Medical's market cap has decreased from 987.00M to 910.00M, a decrease of -7.80%. That is a compound annual growth rate of -0.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 910.00M | 4.20% |
| Dec 31, 2025 | 873.33M | 1.55% |
| Dec 31, 2024 | 860.00M | 0.78% |
| Dec 29, 2023 | 853.33M | 8.47% |
| Dec 30, 2022 | 786.67M | 74.81% |
| Dec 30, 2021 | 450.00M | 28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bionime | 4.38B |
| Nang Kuang Pharmaceutical | 3.64B |
| Maxigen Biotech | 3.55B |
| ICARES Medicus | 3.34B |
| Crystalvue Medical | 1.84B |
| Chi Sheng Pharma & Biotech | 1.75B |
| BenQ Medical Technology | 1.75B |
| Lagis Enterprise | 1.32B |